{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fquadshot-news-podcast.simplecast.com%2Fepisodes%2F2172020-the-maximum-maxim-ijTevOlr","width":444,"version":"1.0","type":"rich","title":"2.17.2020 - The Maximum Maxim","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/d4956b26-f7a3-4f47-a83d-9293649d65c8/ec08e780-4e06-4c01-8109-4e894d682296/qs_sqaure.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/343e2fad-1323-4f23-aedd-145724e7c6fd\" height=\"200\" width=\"100%\" title=\"2.17.2020 - The Maximum Maxim\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"GTR for GBM, Transplants for Breast Cancer, COMBI-AD, Contracture, Bone Met SBRT, PD-L1>90%, MET inhibitor savolitinib, USMLE Step 1\n\nquadshotnews@gmail.com\n@QuadShotNews\n\n"}